LELECHA Valuation, Funding & Investors

LELECHA is valued at $166M as of May 2024.

Last LELECHA valuation

$166M

Strategic investment · May 2024

Last LELECHA funding round

$73M

Strategic investment · May 2024

Cumulative funding LELECHA raised

$192M

across 4 funding rounds

Key investors in LELECHA

  • Vertex Ventures
  • Vertex Ventures China
  • The Hina Group
  • Z&H Investment
  • Prometheus Capital
  • Jun Capital

LELECHA Overview

About LELECHA

LELECHA is a China-headquartered beverage company that blends traditional Chinese tea with European-style bagged packaging formats. The firm produces ready-to-drink teas and develops franchise models for retail distribution. LELECHA operates outlets in major cities and exports products featuring green tea, oolong, and fruit infusions to Asian markets.


Founded

2016

HQ

ChinaShanghai

Status

Privately held

Customer focus

B2B & B2C

Revenue model

Product sales

Valuation

$166M (May 2024)

LELECHA Valuation

LELECHA is currently valued at $166M, based on its strategic investment round in May 2024.

The $73M round was led by Nayuki’s Tea.

LELECHA's valuation has moved from $174M at its undisclosed-stage round in December 2022 to $166M in May 2024, across 2 priced rounds.

LELECHA valuation by funding round

LELECHA valuation by funding round
DateStageValuation
May 2024Strategic investment$166M
Dec 2022Undisclosed stage$174M

LELECHA Funding History

LELECHA has raised a total of $192M across 4 funding rounds.

LELECHA's first fundraising round was a $14M seed round in November 2018. The most recent completed round was a $73M strategic investment round in May 2024.

LELECHA funding rounds

LELECHA funding rounds
DateStageInvestorsRaisedValuationDeal Summary
May 2024Strategic investmentNayuki’s Tea (lead)$73M$166M-
Dec 2022Undisclosed stageNaixuecha (lead)$75M$174MLELECHA is a Chinese bubble tea chain founded in 2016, known initially for its soft bun and milk tea offerings, operating over 100 self-owned stores primarily in prime locations of first-tier cities in east China. The company shifted strategy amid declining popularity, closing flagship stores in cities like Chongqing, Guangzhou, Xi'an, and reducing Beijing outlets from 11 to 7, while expanding in east China to around 148 stores by late 2022. Naixue (Nayuki), a competitor, acquired 43.64% stake for RMB 525 million (US$75 million) around December 2022, becoming the largest shareholder while allowing LELECHA to operate independently with support in expansion, supply chain, digitalization, and management. This investment valued LELECHA at approximately RMB 1.2 billion (US$171.5 million), down 30% from its prior RMB 1.71 billion valuation in a July 2020 financing round and far below unconfirmed 2021 rumors of RMB 4 billion. The deal reflects industry consolidation amid Covid impacts, macroeconomic slowdowns, and shifting consumer spending, with LELECHA's novelty waning against rivals like Naixue and HeyTea. LELECHA reported losses after tax of RMB 20.6 million in 2020 and RMB 18.2 million in 2021 during the pandemic, having broken even pre-Covid per media reports. Naixue's move provides affordable expansion via LELECHA's stores at a per-store valuation drop from prior highs to about RMB 8.1 million. LELECHA had completed four prior funding rounds, with no new financing in over two years before this stake sale. The acquisition boosted Naixue's HKEX shares, signaling market optimism for strategic tie-ups in the new-style tea sector.
Apr 2019SeedVertex Ventures China (lead); The Hina Group; Vertex Ventures; Ruchuan Capital; Prometheus Capital; Jun Capital; Z&H Investment$30M-LELECHA is a Chinese fruit tea brand that secured RMB200 million (approximately US$29.81 million) in a series pre-A funding round on April 3, 2019, led by Vertex Ventures China, with participation from investors including Jun Capital, Prometheus Capital, Ruchuan Capital, The Hina Group, Vertex Ventures, and Z&H Investment. This early-stage investment reflects growing interest in China's consumer tech and beverage sectors, particularly innovative tea brands targeting younger demographics with fruit-infused products. The round aligns with Vertex Ventures China's focus on high-growth startups in consumer tech, as part of their portfolio strategy across mainland China. LELECHA's positioning in the competitive new tea drink market, which includes players emphasizing fresh fruit teas, positioned it for expansion amid rising demand for premium, health-oriented beverages in urban areas.
Nov 2018Seed-$14M--

Who has invested in LELECHA?

9 investors have backed LELECHA across its funding rounds, including Vertex Ventures, Vertex Ventures China, The Hina Group, Z&H Investment, Prometheus Capital and Jun Capital.

Lead investors include Nayuki’s Tea, Naixuecha and Vertex Ventures China.


LELECHA Investors

Investors in LELECHA by funding rounds participated
InvestorHQRoundsRoleFirst check
The Hina GroupUnited StatesSan Francisco, CA1ParticipantApr 2019
Vertex VenturesSingaporeSingapore1ParticipantApr 2019
Ruchuan CapitalChinaXiamen1ParticipantApr 2019
Prometheus CapitalChinaBeijing1ParticipantApr 2019
Vertex Ventures ChinaChinaBeijing1LeadApr 2019
NaixuechaChinaShenzhen1LeadDec 2022
Jun CapitalSingaporeSingapore1ParticipantApr 2019

This data is available for Pro users. Sign up to see all 9 LELECHA investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

LELECHA Competitors

LELECHA competitors include listed companies like Naturhouse Health, Rokiskio Suris, Meysu and Sucro, and private ones like Zihaiguo and Urban Harvest.

Public and private companies comparable to LELECHA
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Naturhouse HealthSpainSpainPublicly listed$55M$17M$165M2.7x
ZihaiguoChinaChongqingPrivate--$169M-
Rokiskio SurisLithuaniaLithuaniaPublicly listed$464M$34M$163M-
MeysuTurkeyTurkeyPublicly listed--$162M-
Urban HarvestIndiaDelhiPrivate--$162M-
SucroUnited StatesUnited StatesPublicly listed$669M$65M$160M0.8x

LELECHA Public Comps

LELECHA is still privately-owned, but its public comps include Naturhouse Health, Rokiskio Suris, Meysu, Sucro, Balsu Gıda, Midsona, HKFoods, Fine Foods, Duncan Fox and Cheffelo.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Naturhouse Health$55M$17M2.8x2.7x8.9x8.9x
Rokiskio Suris$464M$34M0.4x-5.9x-
Meysu------
Sucro$669M$65M0.8x0.8x8.4x17.6x
Balsu Gıda$357M$35M1.2x-12.6x-
Midsona$370M$20M0.5x0.5x9.7x6.1x
HKFoods$1.1B$70M0.4x0.4x6.0x5.6x
Fine Foods$290M$40M1.0x1.0x7.4x7.1x

This data is available for Pro users. Sign up to see all LELECHA competitors and their valuation data.

Start Free Trial

Common questions about LELECHA

When was LELECHA founded?LELECHA was founded in 2016.
Where is LELECHA headquartered?LELECHA is headquartered in Shanghai, China.
Is LELECHA publicly listed?No, LELECHA is a private, VC-backed company.
What is LELECHA's valuation?LELECHA was last valued at $166M in its strategic investment round in May 2024.
How much funding has LELECHA raised?LELECHA has raised $192M across 4 funding rounds.
What was LELECHA's last funding round?LELECHA's last funding round was a $73M strategic investment round in May 2024, led by Nayuki’s Tea.
Who are LELECHA's investors?LELECHA's investors include The Hina Group, Vertex Ventures, Ruchuan Capital, Prometheus Capital, Vertex Ventures China, Naixuecha, Jun Capital, Nayuki’s Tea and Z&H Investment.
Which companies are comparable to LELECHA?Companies comparable to LELECHA include Naturhouse Health, Zihaiguo, Rokiskio Suris, Meysu, Urban Harvest and Sucro.

See companies similar to LELECHA

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial